MYC and colorectal carcinoma: Dioscin downregulates CRC cells (HT-29, HCT-116, and SW480) proliferation and colony formation by promoting FBW-7-mediated c-myc ubiquitination, leading to the downregulation of c-myc and HK2 expression, reduced lactate consumption and glucose absorption, and inhibition of glycolysis.